The answer so far
Vitamin D has an important biological role, but a nutrient being necessary does not mean taking extra prevents every disease. The clearest question is whether a person is deficient or whether a well-designed trial shows benefit for a named outcome.
Vitamin D supports calcium absorption and bone health. Supplementation can correct or prevent deficiency in defined circumstances, while trials of routine supplementation do not show a universal prevention effect for every outcome. Very high supplemental intake can cause harm, so more is not automatically better.1
On this page
Can vitamin D supplements prevent disease? Choose a step to explore this subject in more detail.
Mechanism and outcome are different
A nutrient can be required for normal physiology without acting as a general treatment. Bone outcomes, blood concentrations, falls, mood and cardiovascular events are separate questions and need separate evidence.1
What a large prevention trial found
The US VITAL trial randomly assigned 25,871 adults—men aged 50 or older and women aged 55 or older—to vitamin D3 or placebo; it also separately studied omega-3. Participants had no history of cancer other than non-melanoma skin cancer, or of the cardiovascular conditions excluded by the trial, when enrolled. The vitamin D comparison tested 2,000 IU (50 micrograms) daily; this is a study detail, not an instruction to take that amount. Over a median of 5.3 years, invasive cancer was diagnosed in 793 of 12,927 assigned vitamin D and 824 of 12,944 assigned its placebo. The difference was not statistically significant. The combined outcome of heart attack, stroke or cardiovascular death occurred in 396 people assigned vitamin D and 409 assigned placebo; the difference was not statistically significant. These results do not rule out every possible small effect or prove anything about treating an individual’s deficiency.2
What about broken bones?
A later analysis of the same trial compared fractures: a first fracture occurred in 769 people assigned vitamin D and 782 assigned placebo. The estimated fracture rate was 2% lower with vitamin D, but the 95% confidence interval ranged from 11% lower to 8% higher. The difference was not statistically significant; the interval describes uncertainty about the group comparison, not an individual prediction. Participants were not selected for vitamin D deficiency, low bone mass or osteoporosis, so the result should not be used to dismiss treatment for those conditions. The study tested one daily vitamin D regimen in midlife and older US adults; it does not establish the effect of every regimen or every population. Discuss a prescribed supplement or a concern about deficiency with a clinician.3
Why dose and context matter
Vitamin D comes from food, sunlight and supplements, and products vary in strength and formulation. A clinician may use a different plan to treat a documented deficiency than a population trial used for prevention; this article does not set a dose.1
Recommendations can differ by age and circumstance. For generally healthy people without an established reason for vitamin D treatment or testing, the Endocrine Society’s 2024 guideline suggests against routine supplementation above recommended dietary intakes for adults under 75. It makes conditional suggestions for supplementation in some other groups, including adults aged 75 and older and pregnant people, based on possible benefits; the strength and certainty of evidence vary.4
The guideline also suggests supplementation for children and adolescents aged 1–18 to prevent nutritional rickets and possibly reduce respiratory infections, and for adults with high-risk prediabetes alongside lifestyle changes to reduce progression to diabetes. These are conditional suggestions for specific groups, not proof of benefit for everyone.4
These suggestions do not turn one trial into a universal rule or specify an individual dose. Discuss local guidance and your circumstances with a clinician, especially during pregnancy or when treating a deficiency.
For the different blood tests, unit conversions and safety considerations, see the vitamin D overview.
Too much is a real risk
Excessive supplemental vitamin D can raise calcium and cause symptoms including nausea, weakness, dehydration and kidney problems. For adults, the US NIH Office of Dietary Supplements lists 4,000 IU (100 micrograms) per day from food, drinks and supplements as the tolerable upper intake level; this is a population safety limit, not a target or a guarantee for every person. A clinician may use a different short-term plan to treat documented deficiency. The risk comes mainly from high supplemental intake, not ordinary sunlight exposure. If you are taking a high-dose supplement and develop repeated vomiting, marked weakness, severe thirst or dehydration, seek prompt medical advice; these symptoms can have other causes.1
Further reading
Trusted external resources selected to help explain this page. They open in a new tab.
- NIH ODS: Vitamin D fact sheet ↗
- Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease ↗VITAL primary cancer and cardiovascular outcomes; not a trial of deficiency treatment.
- Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults ↗VITAL fracture analysis; participants were not selected for deficiency or osteoporosis.
Sources, kept close.
Selected supporting sources; this is not a complete literature review.
- Vitamin D — ConsumerNIH Office of Dietary Supplements · Official consumer fact sheet
- Vitamin D Supplements and Prevention of Cancer and Cardiovascular DiseaseNew England Journal of Medicine · Randomized placebo-controlled trial
- Supplemental Vitamin D and Incident Fractures in Midlife and Older AdultsNew England Journal of Medicine · Randomized trial ancillary analysis
- Vitamin D for the Prevention of DiseaseEndocrine Society · Clinical practice guideline, 2024
